These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1363 related articles for article (PubMed ID: 25027972)

  • 1. MicroRNAs in cancer: biomarkers, functions and therapy.
    Hayes J; Peruzzi PP; Lawler S
    Trends Mol Med; 2014 Aug; 20(8):460-9. PubMed ID: 25027972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micromarkers 2.0: an update on the role of microRNAs in cancer diagnosis and prognosis.
    Ferracin M; Negrini M
    Expert Rev Mol Diagn; 2015; 15(10):1369-81. PubMed ID: 26338209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.
    Cho WC
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1273-81. PubMed ID: 20026422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel tumor markers-circulating miRNA].
    Xie L; Qian XP; Liu BR
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):641-2. PubMed ID: 22340041
    [No Abstract]   [Full Text] [Related]  

  • 5. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
    Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
    Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MicroRNA and cancer].
    Kiselev FL
    Mol Biol (Mosk); 2014; 48(2):232-42. PubMed ID: 25850292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel serum microRNA panel to discriminate benign from malignant ovarian disease.
    Langhe R; Norris L; Saadeh FA; Blackshields G; Varley R; Harrison A; Gleeson N; Spillane C; Martin C; O'Donnell DM; D'Arcy T; O'Leary J; O'Toole S
    Cancer Lett; 2015 Jan; 356(2 Pt B):628-36. PubMed ID: 25451316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Circulating microRNAs in lung cancer: prospects for diagnostics, prognosis and prediction of antitumor treatment efficiency].
    Vlasov VV; Rykova EIu; Ponomareva AA; Zaporozhchenko IA; Morozkin ES; Cherdyntseva NV; Laktionov PP
    Mol Biol (Mosk); 2015; 49(1):55-66. PubMed ID: 25916110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetically regulated microRNAs and their prospect in cancer diagnosis.
    Kita Y; Vincent K; Natsugoe S; Berindan-Neagoe I; Calin GA
    Expert Rev Mol Diagn; 2014 Jul; 14(6):673-83. PubMed ID: 24914586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
    Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of microRNAs for cancer diagnostics, prognostication and therapy.
    Garzon R; Marcucci G
    Curr Opin Oncol; 2012 Nov; 24(6):655-9. PubMed ID: 23079782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and head and neck cancer: reviewing the first decade of research.
    Sethi N; Wright A; Wood H; Rabbitts P
    Eur J Cancer; 2014 Oct; 50(15):2619-35. PubMed ID: 25103455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
    Saumet A; Lecellier CH
    Adv Exp Med Biol; 2015; 888():5-15. PubMed ID: 26663176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of protein markers for serum diagnosis of cancer based on microRNA expression profiling].
    Bukurova IuA; Nikitina SL; Khankin SL; Krasnov GS; Lisitsin NA; Karpov VL; Beresten' SF
    Mol Biol (Mosk); 2011; 45(2):376-81. PubMed ID: 21634125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
    Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
    Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA expression signatures in solid malignancies.
    Galasso M; Sandhu SK; Volinia S
    Cancer J; 2012; 18(3):238-43. PubMed ID: 22647360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-18a: a sensitive cancer screening biomarker in human cancer.
    Komatsu S; Ichikawa D; Takeshita H; Morimura R; Hirajima S; Tsujiura M; Kawaguchi T; Miyamae M; Nagata H; Konishi H; Shiozaki A; Otsuji E
    In Vivo; 2014; 28(3):293-7. PubMed ID: 24815829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNAs in cancer: diagnostic and prognostic significance.
    Zhou L; Zhao YP; Liu WJ; Dong J; Chen WY; Zhang TP; Chen G; Shu H
    Expert Rev Anticancer Ther; 2012 Feb; 12(2):283-8. PubMed ID: 22316375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Selection of microRNA for providing tumor specificity of transgene expression in cancer gene therapy].
    Shepelev MV; Kalinichenko SV; Vikhreva PN; Korobko IV
    Mol Biol (Mosk); 2016; 50(2):327-35. PubMed ID: 27239854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.